Balchem (BCPC) Liabilities and Shareholders Equity (2010 - 2026)

Balchem (BCPC) has 17 years of Liabilities and Shareholders Equity data on file, last reported at $1.7 billion in Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $1.7 billion, up 4.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.7 billion (up 5.57% YoY), and the FY2025 annual result was $1.7 billion, up 7.04% from the prior year.
• Liabilities and Shareholders Equity held at $1.7 billion in Q1 2026 per BCPC's latest filing, from $1.7 billion in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $1.7 billion in Q1 2026 and troughed at $1.2 billion in Q1 2022.
• A 5-year average of $1.6 billion and a median of $1.6 billion in 2025 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2022 and 2024: Liabilities and Shareholders Equity surged 38.47% in 2022, then dropped 2.73% in 2024.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $1.6 billion in 2022, then fell by 1.68% to $1.6 billion in 2023, then declined by 1.37% to $1.6 billion in 2024, then advanced by 7.04% to $1.7 billion in 2025, then climbed by 0.44% to $1.7 billion in 2026.
• Business Quant data shows BCPC's Liabilities and Shareholders Equity at $1.7 billion in Q1 2026, $1.7 billion in Q4 2025, and $1.7 billion in Q3 2025.